Helvetica Chimica Acta – Vol. 95 (2012)
1527
137.7, 129.6 (2 arom. C); 129.2, 128.5, 128.4, 127.5, 126.0, 123.9 (10 arom. CH); 66.2 (CH); 60.2 (PhCH2);
54.0, 30.7, 24.2 (3 CH2). HR-ESI-MS: 355.1592 ([M þ 1]þ, C19H23N4OSþ; calc. 355.1587).
1-({[(2S)-1-Benzylpyrrolidine-2-yl]carbonyl}amino)-3-(tert-butyl)thiourea (5d). Yield: 0.321 g
(96%). Colorless crystals. M.p. 154 – 1568 (iPrOH). [a]D25 ¼ ꢀ63 (c ¼ 1.00, CHCl3). IR (KBr): 3306s
1
(NH), 3228s (NH), 2962s, 1652vs (C¼O), 1558s, 1482m, 1362m, 1277m. H-NMR (CDCl3): 9.25 (br. s,
NH); 7.46 – 7.25 (m, 5 arom. H); 6.97 (br. s, NH); 4.01, 3.55 (AB, JAB ¼ 13.2, PhCH2); 3.34 – 3.31 (m, CH);
3.08 – 3.05 (m, 1 H, Pro); 2.39 – 2.35 (m, 1 H, Pro); 2.25 – 2.18 (m, 1 H, Pro); 2.00 – 1.81 (m, 3 H, Pro); 1.51
(s, 3 Me). 13C-NMR (CDCl3): 178.1, 169.6 (C¼O, C¼S); 137.9 (1 arom. C); 129.1, 128.5, 127.5 (5 arom.
CH); 66.2 (CH); 60.2 (PhCH2); 53.9, 30.8, 24.2 (3 CH2); 53.7 (Me3C); 29.0 (Me3C). HR-ESI-MS:
335.1906 ([M þ 1]þ, C17H27N4OSþ; calc. 335.1900).
Suitable crystals of 5d for the X-ray crystal-structure determination were grown from iPrOH.
1-({[(2S)-1-Benzylpyrrolidine-2-yl]carbonyl}amino)-3-butylurea (9). See [7].
4. Synthesis of Optically Active 1,2,4-Triazole-3-thiones 6 and 1,2,4-Triazole-3-one 8. General
Procedure. A mixture of 5 (1 mmol) or 9 [7] (1 mmol), and a 2% aq. soln. of NaOH (5 ml) was heated to
reflux for 2 h. Then, the soln. was neutralized with AcOH, and the formed precipitate was filtered off and
crystallized from H2O.
Racemic 6a was obtained from rac-5a by the same procedure.
5-[(2S)-1-Benzylpyrrolidin-2-yl]-2,4-dihydro-4-methyl-3H-1,2,4-triazole-3-thione (6a). Yield:
0.219 g (80%). Colorless crystals. M.p. 130 – 1328 (H2O). [a]2D5 ¼ ꢀ42 (c ¼ 1.00, CHCl3). IR (KBr):
3142m, 2941s, 2552m (br.), 1571s, 1453m, 1333m, 1071m. 1H-NMR (CDCl3): 11.36 (br. s, HN); 7.29 – 7.18
(m, 5 arom. H); 3.76, 3.41 (AB, JAB ¼ 13.2, PhCH2); 3.71 (s, Me); 3.75 – 3.72 (m, CH); 3.14 – 3.11 (m, 1 H);
2.36 – 2.22 (m, 2 H); 1.99 – 1.89 (m, 3 H). 13C-NMR (CDCl3): 168.9 (C¼S); 152.6, 137.7 (1 arom. C, C(3));
128.7, 128.3, 127.6 (5 arom. CH); 60.8 (CH); 58.5 (PhCH2); 53.6, 29.1, 22.9 (3 CH2); 31.3 (Me). HR-ESI-
MS: 275.1327 ([M þ 1]þ, C17H27N4OSþ; calc. 275.1325).
rac-5-(1-Benzylpyrrolidin-2-yl)-4-methyl-2,4-dihydro-3H-1,2,4-triazole-3-thione (rac-6a). Yield:
0.222 g (81%). Colorless crystals. M.p. 166 – 1678 (H2O).
5-[(2S)-1-Benzylpyrrolidin-2-yl]-4-butyl-2,4-dihydro-3H-1,2,4-triazole-3-thione (6b). See [7].
5-[(2S)-1-Benzylpyrrolidin-2-yl]-2,4-dihydro-4-phenyl-3H-1,2,4-triazole-3-thione (6c). Yield:
0.286 g (85%). Colorless crystals. M.p. 129 – 1318 (H2O). [a]2D5 ¼ ꢀ55 (c ¼ 1.00, CHCl3). IR (KBr):
1
3223m (NH), 3029m, 2934m (br.), 1560m, 1497s, 1312m, 695m. H-NMR (CDCl3): 11.03 (br. s, NH);
7.52 – 7.20 (m, 10 arom. H); 3.86, 3.47 (AB, JAB ¼ 13.2, PhCH2); 3.55 – 3.53 (m, CH); 3.01 – 2.97 (m, 1 H);
2.36 – 2.31 (m, 1 H); 1.98 – 1.61 (m, 4 H). 13C-NMR (CDCl3): 169.5 (C¼S); 154.4, 137.9, 133.6 (2 arom. C,
C(3)); 130.0, 129.6, 128.9, 128.5, 128.3, 127.2 (10 arom. CH); 59.0 (CH); 58.0 (PhCH2); 52.9, 30.7, 22.9
(3 CH2). HR-ESI-MS: 337.1487 ([M þ 1]þ, C19H21N4Sþ; calc. 337.1481).
5-[(2S)-1-Benzylpyrrolidin-2-yl]-4-butyl-2,4-dihydro-3H-1,2,4-triazol-3-one (8). Yield: 0.165 g
(55%). Colorless oil. [a]2D5 ¼ ꢀ39 (c ¼ 1.00, CHCl3). IR (film): 3197m (br., NH), 2959s, 1701vs
1
(C¼O), 1468m, 1102m. H-NMR (CDCl3): 9.63 (br. s, NH); 7.30 – 7.22 (m, 5 arom. H); 3.95 – 3.91 (m,
1 H, CH2 of Bu); 3.86, 3.37 (AB, JAB ¼ 13.2, PhCH2); 3.66 – 3.62 (m, 1 H, CH2 of Bu); 3.57 – 3.54 (m, CH);
3.09 – 3.07 (m, 1 H); 2.30 – 2.20 (m, 2 H); 1.97 – 1.87 (m, 3 H); 1.72 – 1.36 (m, 2 CH2, Bu); 0.94 (t, J ¼ 7.8,
Me). 13C-NMR (CDCl3): 156.4 (C¼O); 148.4, 138.0 (1 arom. C, C(3)); 128.8, 128.2, 127.1 (5 arom. CH);
61.3 (CH); 58.2 (PhCH2); 53.2, 29.5, 22.8 (3 CH2); 41.7, 31.0, 20.1 (3 CH2, Bu); 13.7 (Me). HR-ESI-MS:
301.2026 ([M þ 1]þ, C17H25N4Oþ; calc. 301.2023).
5. Synthesis of 1,3,4-Thiadiazoles 7. General Procedure. A soln. of 5 (1 mmol) in conc. H2SO4 (5 ml)
was kept at r.t. for 1 d. After neutralization of the soln. with dil. NH4OH, the solid product was filtered
off, dried i.v., and crystallized from H2O.
Racemic 7a was obtained from rac-5a by the same procedure.
5-[(2S)-1-Benzylpyrrolidin-2-yl]-N-methyl-1,3,4-thiadiazol-2-amine (7a). Yield: 0.241 g (88%).
Yellowish crystals. M.p. 128 – 1308 (H2O). [a]2D5 ¼ ꢀ78 (c ¼ 1.00, CHCl3). IR (KBr): 3250s (HN),
3024m, 1546s, 1520m, 1153m, 1113m. 1H-NMR (CDCl3): 7.33 – 7.25 (m, 5 arom. H); 5.43 (br. s, NH); 4.02,
3.38 (AB, JAB ¼ 13.2, PhCH2); 3.99 – 3.96 (m, CH); 3.07 – 3.04 (m, 1 H, Me); 2.36 – 2.30 (m, 2 H); 1.96 –
1.80 (m, 3 H). 13C-NMR (CDC13): 171.7, 142.7 (thiadiazol C(2), C(5)); 138.4 (1 arom. C); 128.8, 128.3,
127.2 (5 arom. CH); 63.7 (CH); 58.0 (PhCH2); 53.0, 33.3, 22.9 (3 CH2); 33.2 (Me). HR-ESI-MS: 275.1326
([M þ 1]þ, C14H19N4Sþ; calc. 275.1325).